Independent peptide education · Evidence annotated · Research use information
Peptide Library / Semax

Semax Research Guide

ACTH-derived synthetic peptide

Limited and region-specific
ClassificationSingle Peptide
Evidence tierLimited and region-specific
Research statusEducational reference
01 · At a glance

Overview

Semax is included in this independent research library to separate what has been demonstrated from what remains theoretical. The evidence, regulatory status and terminology vary substantially by compound, so claims should be read in the context of the cited literature.

Dosing & reconstitution guide

Semax suggested dosing guide

A concise reference to the dosing ranges most often used in approved labeling, clinical research, or published research discussions. Evidence strength is shown so established dosing is not confused with experimental protocol.

Limited human evidence
Suggested starting rangeNo US-approved dose
Typical reference range300–600 mcg commonly discussed
FrequencyOne to three times daily
TimingOften earlier in the day
Typical durationOften described as 10–14 days
RouteIntranasal protocols are most commonly described

Titration and protocol notes

Regional clinical products are not equivalent to unapproved compounded preparations.

Annotated dosage protocol

Each row explains what the dosage represents. Read it with the evidence badge above: labeled doses, clinical-trial doses, and commonly discussed research amounts do not carry equal clinical weight.

PhaseDoseScheduleWhat this dosage means
Lower referenceNo US-approved doseOne to three times dailyThe lower end reported in research discussions; it is not a validated human starting prescription.
Commonly cited range300–600 mcg commonly discussedOften earlier in the dayA range repeated in reference protocols. Repetition does not establish safety, efficacy, or an approved regimen.
Duration / reassessmentOften described as 10–14 daysReassess before continuingRegional clinical products are not equivalent to unapproved compounded preparations. Dose changes should never be inferred from vial size or convenient syringe units.

Semax reconstitution example

This worked example uses a 10 mg vial, 2 mL of diluent, and a 300 mcg reference amount.

Vial strength10 mg
Diluent added2 mL
Concentration5 mg/mL
Example draw0.06 mL / 6 units
How this example is calculated: 10 mg ÷ 2 mL = 5 mg/mL. The 300 mcg reference amount equals 0.3 mg. That produces a 0.06 mL draw, or 6 units on a U-100 syringe.

Syringe units assume a U-100 syringe. Always verify the vial label, syringe type, formulation, and arithmetic independently.

Safety, handling, and storage
  • Suggested ranges are educational summaries, not individualized prescriptions.
  • FDA-labeled regimens apply only to the approved product, indication, and delivery system.
  • For experimental compounds, human safety, purity, and effective dosing may be unknown.
  • Follow product-specific sterility, storage, and beyond-use instructions; do not use damaged or contaminated material.
Live concentration math

Semax calculator

Enter your laboratory values to calculate concentration, draw volume, syringe units, and portions per vial.

Runs in your browser
Concentration5 mg/mL
Draw volume0.06 mL
On the syringe6 units
Portions per vial33

Deterministic arithmetic for laboratory documentation only. This tool does not select a dose, provide a protocol, or replace qualified medical or laboratory guidance.

02 · How it is studied

Mechanism and research rationale

A synthetic peptide fragment investigated for neurotrophic, cognitive and ischemia-related mechanisms, primarily in Russian studies.

Neuroprotection

Cognition

Ischemia models

03 · Interpretation

Key facts

  • Evidence tier: Limited and region-specific.
  • Research status and regulatory status are not interchangeable.
  • This page is an educational reference and does not provide personal medical instructions.
04 · Editorial annotations

What to keep in mind

Editorial note: distinguish peer-reviewed findings from supplier or community claims.
Evidence note: study design, species, route and formulation can materially change interpretation.
05 · Sources

References and evidence indexes

  1. PubMed search: Semax
  2. ClinicalTrials.gov search
Research product

Looking for Semax?

View the corresponding Semax research product, specifications, and available documentation from Novatherix Laboratories.

View at Novatherix →

External catalog link. For qualified laboratory and research use only.

Research notice: This guide is educational and not medical advice. It does not diagnose, treat, prescribe, or recommend personal use.
Semax Research Guide | Get Peptide Answers | Get Peptide Answers